Kotańska, M.; Kubacka, M.; Bednarski, M.; Nicosia, N.; Szafarz, M.; Jawień, W.; Müller, C.E.; Kieć-Kononowicz, K.
The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects. Pharmaceuticals 2021, 14, 799.
https://doi.org/10.3390/ph14080799
AMA Style
Kotańska M, Kubacka M, Bednarski M, Nicosia N, Szafarz M, Jawień W, Müller CE, Kieć-Kononowicz K.
The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects. Pharmaceuticals. 2021; 14(8):799.
https://doi.org/10.3390/ph14080799
Chicago/Turabian Style
Kotańska, Magdalena, Monika Kubacka, Marek Bednarski, Noemi Nicosia, Małgorzata Szafarz, Wojciech Jawień, Christa E. Müller, and Katarzyna Kieć-Kononowicz.
2021. "The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects" Pharmaceuticals 14, no. 8: 799.
https://doi.org/10.3390/ph14080799
APA Style
Kotańska, M., Kubacka, M., Bednarski, M., Nicosia, N., Szafarz, M., Jawień, W., Müller, C. E., & Kieć-Kononowicz, K.
(2021). The GPR18 Agonist PSB-KD-107 Exerts Endothelium-Dependent Vasorelaxant Effects. Pharmaceuticals, 14(8), 799.
https://doi.org/10.3390/ph14080799
